, Volume 474, Issue 1, pp 13–13 | Cite as

Oral Acetazolamide in the Treatment of Menière’s Disease

Newsletter Article


Severe Symptom Sustained Release Significant Benefit Acetazolamide Poor Compliance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1985

Personalised recommendations